Showing 1,450 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Copy of Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
Pharmaceutical industry

Drugmakers offer to cap Greece's medicines bill

Editor's pick
Reuters
6 November 2012
Pharmaceutical industry

Gilead and the Pharmasset Deal: Do the Ends Justify the Means?

Editor's pick
PropThink
5 November 2012
Access to healthcare

Hope for hep-c patients: Patients succeed in overturning first ever product patent on medicine in India

Editor's pick
Lawyers' Collective
2 November 2012
New & experimental hepatitis C treatment

Vertex Joins Glaxo, J&J in Testing Hepatitis C Combos

Editor's pick
Bloomberg BusinessWeek
1 November 2012
New & experimental HIV treatments

Gilead: HIV drug meets key Phase 2 trial objective

Editor's pick
Gilead press release
31 October 2012
New & experimental hepatitis C treatment

Achillion Pharma Worthy of New Look - TheStreet.com

Editor's pick
Google Alerts - Hepatitis
31 October 2012
Hepatitis C symptoms & diagnosis

bioMérieux launches antibody test for hepatitis C

Editor's pick
MTBeurope
31 October 2012
HIV treatment for children & young people

Prezista® (darunavir) oral suspension receives European Commission approval for young children with HIV-1 infection

Editor's pick
Janssen-Cilag press release
30 October 2012
Pharmaceutical industry

Glaxo & Pfizer rejig joint venture deal with Shionogi

Editor's pick
ShareCast
29 October 2012
Pharmaceutical industry

Buy Gilead Sciences: HIV And Hepatitis Drugs To Drive Growth

Editor's pick
Seeking Alpha
25 October 2012
Pharmaceutical industry

Gilead Sciences Revenue Jumps 14%, Helped by HIV Drugs

Editor's pick
NASDAQ
24 October 2012
Pharmaceutical industry

Questions and answers on the assessment of the deficiencies in the safety reporting system at Roche Registration Ltd

Editor's pick
European Medicines Agency
23 October 2012
Pharmaceutical industry

Humira drives Abbott growth again, 550 jobs cut

Editor's pick
Pharma Times
19 October 2012
Pharmaceutical industry

India's Cipla gets tentative U.S. nod for HIV tablets

Editor's pick
Reuters
19 October 2012
Pharmaceutical industry

Vertex Draws Collaboration Interest For Hepatitis C Combo

Editor's pick
Bloomberg BusinessWeek
19 October 2012
Pharmaceutical industry

BioCryst scoops up early-stage Hep C drugs in $101M Presidio acquisition

Editor's pick
FierceBiotech
18 October 2012
New & experimental hepatitis C treatment

A New And Interesting Addition To The Hep C Clinical Pipeline

Editor's pick
Seeking Alpha
18 October 2012
Pharmaceutical industry

GlaxoSmithKline To Make Clinical Trial Data Available To Other Researchers

Editor's pick
Kaiser Daily Global Health Policy Report
15 October 2012
Pharmaceutical industry

Tanzania investigates fake HIV drugs

Editor's pick
BBC News
12 October 2012
Access to healthcare

Indonesia in bold move to obtain cheap drugs for HIV

Editor's pick
The Guardian
12 October 2012
Bad science & bogus treatments

Tanzania: Factory Closed Over Fake Ante-Retrovirals

Editor's pick
allAfrica.com
11 October 2012
TB transmission & prevention

Aeras signs agreement with GSK to jointly advance TB vaccine

Editor's pick
Eurekalert Medicine & Health
10 October 2012
The search for a cure

Could Sangamo's 'functional cure' for HIV disrupt the drug market?

Editor's pick
MarketWatch (blog)
5 October 2012